These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11082986)

  • 1. [Assessment of the effectiveness of using low molecular weight heparin in the prophylaxis of venous thrombo-embolic diseases in obstetrics].
    Tomiałowicz M; Florjański J; Zimmer M; Pajak J; Kłósek A
    Ginekol Pol; 2000 Sep; 71(9):1115-9. PubMed ID: 11082986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The course of pregnancy, delivery and puerperium in women with varices and thrombophlebitis of lower extremities, after application of low molecular weight heparins].
    Florjański J; Zalewski J; Tomiałowicz M; Heimrath J; Pajak J; Fuchs T; Kłósek A; Klyszcz B
    Ginekol Pol; 2001 Dec; 72(12A):1291-5. PubMed ID: 11883266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease.
    Bergqvist D
    Aust N Z J Surg; 1998 Jul; 68(7):463-8. PubMed ID: 9669358
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M; Broholm R; Bækgaard N
    Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pregnant women with increased risk of venous thrombosis.
    Dargaud Y; Rugeri L; Ninet J; Negrier C; Trzeciak MC
    Int J Gynaecol Obstet; 2005 Sep; 90(3):203-7. PubMed ID: 15964002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the role of low-molecular-weight heparins in pregnancy.
    Greer IA
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery.
    Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F
    Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy and prevention of deep venous thrombosis and pulmonary embolism in gynecology and obstetrics].
    Vucić N; Cala K; Rancić I; Pticar R
    Acta Med Croatica; 2003; 57(2):123-30. PubMed ID: 12879692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylaxis of pulmonary embolism in pregnancy and puerperium].
    Kostrubiec M; Niewegłowska N; Pruszczyk P
    Ginekol Pol; 2010 Jan; 81(1):46-9. PubMed ID: 20232699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["How must deep leg venous thrombosis be diagnosed and treated?"].
    Bruhn HD
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1730-1. PubMed ID: 12920673
    [No Abstract]   [Full Text] [Related]  

  • 13. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 14. [Deep venous thrombosis--treatment].
    Fries R; Böhm M
    Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy.
    Ní Ainle F; Wong A; Appleby N; Byrne B; Regan C; Hassan T; Milner M; Sullivan AO; White B; O'Donnell J
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):689-92. PubMed ID: 18832911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Annu Rev Med; 1997; 48():79-91. PubMed ID: 9046947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study on the use of a low-molecular-weight heparin for thromboembolism prophylaxis in large-volume liposuction and body contouring procedures.
    Newall G; Ruiz-Razura A; Mentz HA; Patronella CK; Ibarra FR; Zarak A
    Aesthetic Plast Surg; 2006; 30(1):86-95; discussion 96-7. PubMed ID: 16404651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.
    Superficial Thrombophlebitis Treated By Enoxaparin Study Group
    Arch Intern Med; 2003 Jul; 163(14):1657-63. PubMed ID: 12885680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.